CLDN1 and colorectal carcinoma: Low CLDN1 expression is associated with advanced-stage tumours and poor prognosis in CRC patients, while no correlations have been found between the immunoreactivity of this protein and gender, tumour differentiation, depth of invasion, and lymph node involvement [32].